publication . Article . 2017


Open Access Russian
  • Published: 01 Dec 2017 Journal: Klinicist, volume 11, issue 2, pages 16-23 (issn: 1818-8338, Copyright policy)
  • Publisher: ABV-press
Currently, differential diagnosis of systemic bacterial infection and active rheumatic process remains a challenging problem in rheumatology. In the review, current data on the role of procalcitonin biomarker in diagnosis and differential diagnosis of rheumatic diseases (RD) and infectious pathology are presented. In particular, some authors recommend procalcitonin (PCT) test as a marker of bacterial infection in bones and joints at levels above 0.5 ng/ml; at PCT level below 0.3 ng/ml, infection can be ruled out. In patients with microcrystalline arthritis, data on the significance of PCT for differential diagnosis are contradictory. PCT level doesn’t correlate ...
Persistent Identifiers
Medical Subject Headings: hormones, hormone substitutes, and hormone antagonistsparasitic diseasesbacterial infections and mycosescongenital, hereditary, and neonatal diseases and abnormalities
free text keywords: procalcitonin, procalcitonin testing, rheumatic diseases, systemic infection, septic arthritis, systemic lupus erythematosus, rheumatic arthritis, systemic vasculitis, granulomatosis with polyangiitis, adult-onset still’s disease, lcsh:Medicine, lcsh:R, Intensive care, Arthritis, medicine.disease, medicine, business.industry, business, SOFA score, Biomarker (medicine), Internal medicine, medicine.medical_specialty, Rheumatology
Download fromView all 2 versions
Article . 2017
Article . 2017
Provider: Crossref
Provider: UnpayWall
Any information missing or wrong?Report an Issue